# Clinical trials recruiting in Panama: 34 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 34 trials recruiting or not yet recruiting with a site in Panama, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Panama: 34 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/panama

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 34
- Recruiting or not yet: 34
- Read on: November 19, 2026

## Trials

The 25 newest of 34, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 22, 2026 | NCT07889492 | A Study of EB06 Versus Placebo in Adults With Moderate to Severe Non-segmental Vitiligo | Edesa Biotech Inc. | Phase 2 | Recruiting | Non-Segmental Vitiligo (NSV) | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07889492) |
| September 9, 2026 | NCT07809113 | PCV21 Acceptance in Adults ≥50 Years and Caregivers in Panama | Endpoints Site Network | Observational | Not yet recruiting | Pneumococcal Immunization | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07809113) |
| September 9, 2026 | NCT07808697 | A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to \<12 Years of Age | ModernaTX, Inc. | Phase 2 | Recruiting | SARS-CoV-2 | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07808697) |
| August 4, 2026 | NCT07745621 | Vivifi Device Safety Evaluation for the Treatment of Benign Prostatic Hyperplasia | Vivifi Medical | Not applicable | Not yet recruiting | Benign Prostatic Hyperplasia | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07745621) |
| July 21, 2026 | NCT07717320 | Suicidal Risk in Adults in Panama: Validation of a Clinical Intervention Protocol | Fundación Judío Panameña (JUPA) | Not applicable | Not yet recruiting | Suicide Risk | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07717320) |
| April 21, 2026 | NCT07542184 | Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Panama | Nanochon, Inc. | Not applicable | Recruiting | Knee Cartilage Lesions | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07542184) |
| January 28, 2026 | NCT07371468 | A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD) | GlaxoSmithKline | Phase 1 | Recruiting | Systemic Lupus Erythematosus | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07371468) |
| December 16, 2025 | NCT07286331 | A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based... | GlaxoSmithKline | Phase 3 | Recruiting | Neoplasms, Endometrial | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07286331) |
| December 3, 2025 | NCT07261956 | Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia | Saint Thomas Hospital, Panama | Not applicable | Recruiting | Pulmonary Edema - Acute, Preeclampsia | 202 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07261956) |
| November 25, 2025 | NCT07249996 | Respiratory Infections in Young Children | Sponsor not shown (see the record) | Observational | Recruiting | Respiratory Tract Infections (RTI), Lower Respiratory Tract Infection (LRTI), Viral Infections, Cohort Study | 1,088 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07249996) |
| November 21, 2025 | NCT07243405 | Neurostimulation for Sleep Disordered Breathing (SDB) | Lunair Medical | Not applicable | Recruiting | Sleep Disordered Breathing (SDB), Sleep Apnea | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07243405) |
| July 11, 2025 | NCT07060222 | Intestinal Preparation in Colonoscopy: Lactulose vs Sodium Phosphate. | Hospital Civil de Guadalajara | Phase 4 | Recruiting | Bowel Preparation for Colonoscopy | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07060222) |
| June 25, 2025 | NCT07036510 | Safety and Efficacy of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract Surgery | EyeD Pharma | Phase 1/2 | Recruiting | Glaucoma, Ocular Hypertension | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07036510) |
| May 30, 2025 | NCT06997159 | A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active... | Sponsor not shown (see the record) | Phase 2 | Not yet recruiting | Localized Cutaneous Leishmaniasis | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06997159) |
| March 26, 2025 | NCT06895486 | Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation | Sponsor not shown (see the record) | Phase 2 | Recruiting | Poliomyelitis | 675 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06895486) |
| March 19, 2025 | NCT06885034 | A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal... | GlaxoSmithKline | Phase 1/2 | Recruiting | Gastrointestinal Neoplasms | 346 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06885034) |
| February 11, 2025 | NCT06819878 | A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately... | Hoffmann-La Roche | Phase 3 | Recruiting | Moderately to Severely Active Crohns Disease | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06819878) |
| January 28, 2025 | NCT06796907 | A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2) | GlaxoSmithKline | Phase 1/2 | Recruiting | Tumours, Gynecological | 305 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06796907) |
| January 13, 2025 | NCT06772142 | Early Feasibility of the Nervonik Peripheral Nerve Stimulation Device | Nervonik | Early phase 1 | Recruiting | Peripheral Nerve Disorder | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06772142) |
| August 27, 2024 | NCT06572384 | A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease | GlaxoSmithKline | Phase 3 | Recruiting | Lung Diseases, Interstitial | 440 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06572384) |
| August 13, 2024 | NCT06551142 | A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD) | GlaxoSmithKline | Phase 1 | Recruiting | Neoplasms | 845 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06551142) |
| May 22, 2024 | NCT06424912 | Vivifi's Treatment, BPH Treatment Via Vasculature Anastomosis | Vivifi Medical | Not applicable | Recruiting | Benign Prostatic Hyperplasia, Varicocele Grade II, Varicocele Grade III | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06424912) |
| March 29, 2024 | NCT06337032 | A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV... | Gilead Sciences | Phase 4 | Recruiting | HIV-1-infection | 350 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06337032) |
| December 12, 2023 | NCT06166303 | Number of Previous Cesarean Sections on the Results of Angiogenic Factors. | Saint Thomas Hospital, Panama | Observational | Not yet recruiting | Cesarean Section | 540 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06166303) |
| November 8, 2023 | NCT06123377 | Angiogenic Factors in the Conservative Management of Gestational Hypertension | Saint Thomas Hospital, Panama | Not applicable | Recruiting | Gestational Hypertension | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06123377) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Hospital Paitilla | Panama City | 3 |
| Hospital Santo Tomas | Panama City | 3 |
| Panama Eye Center | Panama City | 2 |
| Hospital Punta Pacifica | Panama City | 1 |
| Instituto Conmemorativo Gorgas de Estudios de la Salud | Panama City | 1 |
| Universidad Interamericana de Panamá | Panama City | 1 |
| Hospital del Niño | Panama City | 1 |
| Pacífica Salud Hospital Punta Pacífica | Panama City | 1 |
| Centro Oncologico de Panama | Panama City | 1 |
| Instituto de Investigación e Innovación y Gestión del Conocimiento (III-GC) | Panama City | 1 |
| The Panama Clinic | Panama City | 1 |
| Hospital Gustavo Nelson Collado Ríos Panamá. | Panamá | 1 |
| Saint Thomas Hospital | Panama City | 1 |
| Panama City Health Ministry Clinics | Panama City | 1 |
| Instituto de Investigaciones Cienti-ficas Y Servicios de Alta Tecnologia Asociacion de Interes Panama; . Centro de Investigación, Innovación y Gestión del Conocimiento de Ciudad de la Salud, Caja de Seguro social | Panama City | 1 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 1 | 3 |
| Phase 1/2 | 3 |
| Phase 2 | 5 |
| Phase 3 | 5 |
| Phase 4 | 2 |
| Not applicable | 11 |
| Observational | 4 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Pre-Eclampsia | 3 |
| Neoplasms | 2 |
| Prostatic Hyperplasia | 2 |
| Hypertension, Pregnancy-Induced | 2 |
| Virus Diseases | 2 |
| Poliomyelitis | 2 |
| Neuritis | 1 |
| Gastrointestinal Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Lung Diseases, Interstitial | 1 |
| Connective Tissue Diseases | 1 |
| Autoimmune Diseases | 1 |
| Lung Diseases | 1 |
| Sleep Apnea Syndromes | 1 |
| Urologic Diseases | 1 |
| Nervous System Diseases | 1 |
| Cardiovascular Diseases | 1 |
| Digestive System Diseases | 1 |
| Intracranial Aneurysm | 1 |
| Renal Insufficiency | 1 |
| Coronary Artery Disease | 1 |
| Varicocele | 1 |
| Endometrial Neoplasms | 1 |
| Glaucoma, Open-Angle | 1 |
| Asthma | 1 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 7 |
| Saint Thomas Hospital, Panama | 3 |
| Vivifi Medical | 2 |
| Nervonik | 1 |
| Edesa Biotech Inc. | 1 |
| Lunair Medical | 1 |
| TriAgenics Inc | 1 |
| [Medtronic](https://specstream.ai/data/clinical-trials/company/medtronic) | 1 |
| [Gilead Sciences](https://specstream.ai/data/clinical-trials/company/gilead-sciences) | 1 |
| Myra Vision Inc. | 1 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 1 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 1 |
| Endpoints Site Network | 1 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 1 |
| EyeD Pharma | 1 |
| Nanochon, Inc. | 1 |
| Hospital Civil de Guadalajara | 1 |
| Fundación Judío Panameña (JUPA) | 1 |
| [ModernaTX, Inc.](https://specstream.ai/data/clinical-trials/company/modernatx-inc) | 1 |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Home inspectors in the United States](https://specstream.ai/data/businesses/home-inspectors/united-states)
- [Flour mills in the United States](https://specstream.ai/data/businesses/flour-mills/united-states)
- [Electronic equipment suppliers in the United States](https://specstream.ai/data/businesses/electronic-equipment-suppliers/united-states)
- [Countertop installers in the United States](https://specstream.ai/data/businesses/countertop-installers/united-states)
- [Cardiothoracic surgery practices in the United States](https://specstream.ai/data/businesses/cardiothoracic-surgery-practices/united-states)
- [Bankruptcy law firms in the United States](https://specstream.ai/data/businesses/bankruptcy-law-firms/united-states)
